Lipsore (Aciclovir)

Aciclovir is converted inside infected cells to aciclovir‑triphosphate, which selectively inhibits viral DNA polymerase. By blocking the synthesis of viral DNA, the drug prevents replication of herpes simplex and varicella‑zoster viruses, limiting the spread of infection while sparing normal host cells.

The dosage of Lipsore is determined by the prescribing healthcare professional based on the type, size and location of the lesion. The prescriber will specify how often the cream or gel should be applied and for how many days, ensuring safe and effective use.

Safety data for topical aciclovir in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their physician.

To request Lipsore, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Lipsore provides a localized, topical approach, whereas oral aciclovir or valacyclovir treat systemic infection and may be preferred for extensive disease. Compared with penciclovir cream, aciclovir has a similar efficacy profile but differs in pharmacokinetics; choice depends on physician assessment of lesion severity and patient preference.

Lipsore should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not use the product after the expiration date printed on the label.

The prescribed amount of Lipsore is applied directly to clean, dry skin over the affected area, usually several times daily as directed by the prescriber. Gently spread a thin layer and allow it to dry before covering the lesion with a dressing, if advised.

Although rare, serious adverse reactions can include severe allergic dermatitis, Stevens‑Johnson syndrome, or other severe skin eruptions. Patients should stop using the product and seek immediate medical attention if they notice extensive rash, swelling, blistering, or systemic symptoms such as fever.

Lipsore should not be used on patients with known hypersensitivity to aciclovir or any excipients in the formulation. It is also contraindicated on mucous membranes, deep or extensive wounds, and in individuals with severe immunosuppression where systemic therapy is required.